Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

6.12 

0.00 0.0%

as of Sep 29 '22

52 Week Range:

6.03 7.75


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Daicel Corporation manufactures and sells cellulosic derivatives, organic chemicals, plastics, pyrotechnic devices, and other products in Japan, Asia, North America, and Europe. It operates through Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and Others segments. The company offers 1,3-Butylene glycol, polyglycerin, and thickener for cosmetics; natural health food materials and supplements; and chiral and achiral columns, chiral reagents, bio reagents, and DNA and RNA-based probes, as well as analytical/purification/synthesis/formulation services, and analytical tools services for pharmaceuticals. It also provides triacetylcellulose and films for display market; solvent for electronic materials, polymers for resist, and semiconductor process cleaning agents; and optical parts and lens units, silver nanoparticle inks, and organic semiconductor devices for visualization technology. In addition, the company offers inflators for air bags and pyro-fuse for automotive market, as well as safety device for non-mobility products; acetic acid and derivatives, cellulose acetate, acetate tow, and other raw materials for resins and inks, and solvents for paints; and cycloaliphatic epoxies, caprolactone, ketene derivatives, alkylamines, and other raw materials for electrical materials and coatings. Further, it provides a range of plastics, such as engineering plastics, plastic compound products, functional sheets, formed trays, and packaging films for engineering plastics segment. Additionally, the company manufactures and distributes water treatment systems and diffusers for a range of industrial applications. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Equity (BVPS) 6.88
7.34
11.19
growth rate 3.3% 8.8%
Earnings BIT 37,912.00
51,304.00
64,350.00
64,306.00
58,933.00
51,171.00
29,646.00
31,724.00
50,698.00
growth rate 35.3% 25.4% -0.1% -8.4% -13.2% -42.1% 7.0% 59.8%
Avg.PE 12.78
10.19
11.11
11.11
13.16
5.52
growth rate -20.3% 9.0% 0.0% 18.5% -58.1%
ROA 2.92
3.58
4.70
5.81
7.16
7.45
5.96
5.44
0.79
3.18
growth rate 22.6% 31.3% 23.6% 23.2% 4.1% -20.0% -8.7% -85.5% 302.5%
ROE 5.50
6.70
8.97
10.54
12.19
12.22
9.82
9.07
1.32
6.57
growth rate 21.8% 33.9% 17.5% 15.7% 0.3% -19.6% -7.6% -85.5% 397.7%
ROIC 4.17
4.99
6.51
8.12
9.95
10.28
8.15
7.31
1.16
4.26
growth rate 19.7% 30.5% 24.7% 22.5% 3.3% -20.7% -10.3% -84.1% 267.2%
Cur. Ratio 1.94
2.05
2.25
2.49
2.70
2.81
2.99
2.82
2.81
2.78
growth rate 5.7% 9.8% 10.7% 8.4% 4.1% 6.4% -5.7% -0.4% -1.1%
Quick Ratio 1.10
1.16
1.33
1.36
1.47
1.69
1.88
1.68
1.51
1.64
growth rate 5.5% 14.7% 2.3% 8.1% 15.0% 11.2% -10.6% -10.1% 8.6%
Leverage 1.83
1.92
1.89
1.74
1.66
1.62
1.67
1.66
1.65
2.69
growth rate 4.9% -1.6% -7.9% -4.6% -2.4% 3.1% -0.6% -0.6% 63.0%
Balance Sheet Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Acct.Receivable 81,516.00
89,910.00
86,455.00
84,347.00
88,227.00
93,212.00
90,106.00
79,433.00
93,128.00
102,529.00
growth rate 10.3% -3.8% -2.4% 4.6% 5.7% -3.3% -11.8% 17.2% 10.1%
Acct.Payable 47,444.00
52,720.00
47,960.00
50,108.00
46,575.00
56,213.00
53,933.00
45,007.00
49,419.00
61,888.00
growth rate 11.1% -9.0% 4.5% -7.1% 20.7% -4.1% -16.6% 9.8% 25.2%
Cur.Assets 232,201.00
261,046.00
279,788.00
276,828.00
307,216.00
354,567.00
354,038.00
298,040.00
312,524.00
360,247.00
growth rate 12.4% 7.2% -1.1% 11.0% 15.4% -0.2% -15.8% 4.9% 15.3%
Total Assets 461,513.00
509,834.00
565,332.00
560,190.00
599,708.00
644,078.00
654,791.00
597,992.00
640,385.00
698,836.00
growth rate 10.5% 10.9% -0.9% 7.1% 7.4% 1.7% -8.7% 7.1% 9.1%
Cash 53,238.00
62,574.00
66,738.00
66,040.00
96,586.00
125,358.00
114,044.00
80,751.00
90,827.00
88,130.00
growth rate 17.5% 6.7% -1.1% 46.3% 29.8% -9.0% -29.2% 12.5% -3.0%
Inventory 82,977.00
89,832.00
107,101.00
104,886.00
100,657.00
109,295.00
126,153.00
117,414.00
108,659.00
142,002.00
growth rate 8.3% 19.2% -2.1% -4.0% 8.6% 15.4% -6.9% -7.5% 30.7%
Cur.Liabilities 113,226.00
115,894.00
112,573.00
102,667.00
109,327.00
118,409.00
125,509.00
106,226.00
112,566.00
153,898.00
growth rate 2.4% -2.9% -8.8% 6.5% 8.3% 6.0% -15.4% 6.0% 36.7%
Liabilities 198,613.00
214,029.00
209,154.00
191,470.00
200,280.00
230,538.00
231,549.00
205,410.00
395,385.00
419,294.00
growth rate 7.8% -2.3% -8.5% 4.6% 15.1% 0.4% -11.3% 92.5% 6.1%
LT Debt 66,768.00
71,631.00
64,897.00
58,709.00
59,983.00
75,884.00
76,043.00
72,200.00
255,571.00
236,029.00
growth rate 7.3% -9.4% -9.5% 2.2% 26.5% 0.2% -5.1% 254.0% -7.7%
Equity 268,612.00
324,167.00
337,424.00
369,619.00
384,875.00
393,597.00
362,544.00
237,852.00
272,016.00
growth rate 20.7% 4.1% 9.5% 4.1% 2.3% -7.9% -34.4% 14.4%
Common Shares 353.00
352.00
352.00
351.00
350.00
347.00
36,275.00
36,275.00
36,275.00
36,275.00
36,275.00
growth rate -0.3% 0.0% -0.3% -0.3% -0.9% 10,353.9% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Capital Expenditures 26,067.00
28,026.00
29,629.00
34,694.00
37,201.00
32,110.00
41,647.00
44,127.00
34,698.00
43,494.00
growth rate 7.5% 5.7% 17.1% 7.2% -13.7% 29.7% 6.0% -21.4% 25.4%
Cash Dividends 4,573.00
5,973.00
9,105.00
9,036.00
11,412.00
10,783.00
10,410.00
10,415.00
9,645.00
growth rate 30.6% 52.4% -0.8% 26.3% -5.5% -3.5% 0.1% -7.4%
Cash From OA 44,480.00
44,778.00
57,413.00
65,419.00
86,168.00
66,888.00
58,523.00
57,193.00
57,869.00
42,993.00
growth rate 0.7% 28.2% 13.9% 31.7% -22.4% -12.5% -2.3% 1.2% -25.7%
FCF per Share 0.46
0.60
0.52
growth rate 14.2% -2.8%
FCF 16,607.00
18,414.00
16,752.00
27,783.00
29,569.00
48,155.00
33,456.00
14,944.00
10,880.00
21,080.00
-501.00
growth rate 10.9% -9.0% 65.9% 6.4% 62.9% -30.5% -55.3% -27.2% 93.8% -100.0%
Income Statement Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Sales 358,514.00
413,786.00
443,776.00
449,878.00
440,061.00
462,956.00
464,859.00
412,826.00
393,568.00
467,937.00
growth rate 15.4% 7.3% 1.4% -2.2% 5.2% 0.4% -11.2% -4.7% 18.9%
Op.Income 17,792.00
37,912.00
51,304.00
64,350.00
64,306.00
58,933.00
51,171.00
29,646.00
31,724.00
50,698.00
growth rate 113.1% 35.3% 25.4% -0.1% -8.4% -13.2% -42.1% 7.0% 59.8%
IBT 40,824.00
52,948.00
63,490.00
64,372.00
59,229.00
53,733.00
16,655.00
33,040.00
46,282.00
growth rate 29.7% 19.9% 1.4% -8.0% -9.3% -69.0% 98.4% 40.1%
Net Income 17,792.00
22,844.00
31,253.00
40,313.00
43,198.00
37,062.00
35,301.00
4,978.00
19,713.00
31,254.00
growth rate 28.4% 36.8% 29.0% 7.2% -14.2% -4.8% -85.9% 296.0% 58.6%
EPS 33.46
43.71
64.98
88.95
115.02
124.61
107.81
105.38
15.49
65.18
growth rate 30.6% 48.7% 36.9% 29.3% 8.3% -13.5% -2.3% -85.3% 320.8%
Gross Profit 80,870.00
97,579.00
116,148.00
133,829.00
136,832.00
137,202.00
133,773.00
111,052.00
111,432.00
138,608.00
growth rate 20.7% 19.0% 15.2% 2.2% 0.3% -2.5% -17.0% 0.3% 24.4%
R&D 14,638.00
14,638.00
14,638.00
16,117.00
18,015.00
19,690.00
20,328.00
18,567.00
19,667.00
growth rate 0.0% 0.0% 10.1% 11.8% 9.3% 3.2% -8.7% 5.9%

Quarterly Statements

Item Name Mar '21 Jun '21 Sep '21 Dec '21 Mar '22
Earnings BIT 12,997.00
13,945.00
13,315.00
12,021.00
11,417.00
growth rate 7.3% -4.5% -9.7% -5.0%
Balance Sheet Mar '21 Jun '21 Sep '21 Dec '21 Mar '22
Acct.Receivable 93,128.00
86,676.00
87,327.00
99,657.00
102,529.00
growth rate -6.9% 0.8% 14.1% 2.9%
Acct.Payable 49,419.00
51,145.00
55,203.00
57,742.00
61,888.00
growth rate 3.5% 7.9% 4.6% 7.2%
Cur.Assets 312,524.00
316,125.00
323,314.00
334,302.00
360,247.00
growth rate 1.2% 2.3% 3.4% 7.8%
Total Assets 640,385.00
657,437.00
674,010.00
679,646.00
698,836.00
growth rate 2.7% 2.5% 0.8% 2.8%
Cash 90,827.00
85,255.00
91,081.00
75,219.00
88,130.00
growth rate -6.1% 6.8% -17.4% 17.2%
Inventory 108,659.00
117,735.00
123,524.00
130,050.00
142,002.00
growth rate 8.4% 4.9% 5.3% 9.2%
Cur.Liabilities 112,566.00
114,202.00
130,686.00
143,935.00
153,898.00
growth rate 1.5% 14.4% 10.1% 6.9%
Liabilities 395,385.00
398,446.00
399,668.00
410,687.00
419,294.00
growth rate 0.8% 0.3% 2.8% 2.1%
LT Debt 255,571.00
254,387.00
236,827.00
235,682.00
236,029.00
growth rate -0.5% -6.9% -0.5% 0.2%
Equity 237,852.00
251,987.00
267,938.00
262,107.00
272,016.00
growth rate 5.9% 6.3% -2.2% 3.8%
Common Shares 36,275.00
36,275.00
36,275.00
36,275.00
36,275.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '21 Jun '21 Sep '21 Dec '21 Mar '22
Income Statement Mar '21 Jun '21 Sep '21 Dec '21 Mar '22
Sales 112,209.00
111,358.00
113,459.00
118,162.00
124,958.00
growth rate -0.8% 1.9% 4.2% 5.8%
Op.Income 12,997.00
13,945.00
13,315.00
12,021.00
11,417.00
growth rate 7.3% -4.5% -9.7% -5.0%
IBT 13,907.00
15,120.00
14,471.00
3,634.00
13,057.00
growth rate 8.7% -4.3% -74.9% 259.3%
Net Income 8,479.00
12,283.00
9,763.00
1,456.00
7,752.00
growth rate 44.9% -20.5% -85.1% 432.4%
Gross Profit 34,801.00
35,467.00
34,467.00
33,010.00
35,664.00
growth rate 1.9% -2.8% -4.2% 8.0%
R&D 18,567.00
19,667.00
19,667.00
19,667.00
19,667.00
growth rate 5.9% 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

E (22.02)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 17.64 17.64
EPS / Growth 0.0% 0.35

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 0.0% 0.5% 0.5%
Future PE 0.00 0.51 0.51
Future EPS 0.35 0.36 0.36
Value Price
MOS %
0.00
-100.0%
0.05
-99.3%
0.05
-99.3%
MOS Price 0.00 0.02 0.02
IRT 17.64 16.86 16.86

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.